Morgan Stanley Lexicon Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 454,977 shares of LXRX stock, worth $377,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares

454,977

Previous 354,036 28.51%

Holding current value

$377,630

Previous $594,000 20.2%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $152,420 - $241,248	100,941 Added 28.51%	454,977 $714,000
Q2 2024 Oct 17, 2024	BUY	$1.54 - $2.28 $169,133 - $250,405	109,827 Added 44.97%	354,036 $594,000
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $169,133 - $250,405	109,827 Added 44.97%	354,036 $594,000
Q1 2024 Oct 17, 2024	SELL	$1.3 - $3.58 $142,775 - $393,180	-109,827 Reduced 31.02%	244,209 $586,000
Q1 2024 Aug 16, 2024	SELL	$1.3 - $3.58 $875,522 - $2.41 Million	-673,479 Reduced 73.39%	244,209 $586,000
Q1 2024 May 15, 2024	SELL	$1.3 - $3.58 $875,522 - $2.41 Million	-673,479 Reduced 73.39%	244,209 $586,000
Q4 2023 Aug 16, 2024	BUY	$1.0 - $1.53 $563,652 - $862,387	563,652 Added 159.21%	917,688 $1.4 Million
Q4 2023 Feb 13, 2024	BUY	$1.0 - $1.53 $678,068 - $1.04 Million	678,068 Added 282.98%	917,688 $1.4 Million
Q3 2023 Nov 15, 2023	SELL	$1.06 - $2.33 $37,018 - $81,370	-34,923 Reduced 12.72%	239,620 $261,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $163,913 - $266,074	76,239 Added 38.45%	274,543 $628,000
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $124,299 - $167,398	62,462 Added 45.98%	198,304 $481,000
Q4 2022 Feb 14, 2023	SELL	$1.8 - $2.56 $59,833 - $85,096	-33,241 Reduced 19.66%	135,842 $259,000
Q3 2022 Nov 14, 2022	SELL	$1.94 - $3.43 $775,660 - $1.37 Million	-399,825 Reduced 70.28%	169,083 $405,000
Q2 2022 Oct 27, 2022	BUY	$1.31 - $2.69 $500,847 - $1.03 Million	382,326 Added 204.91%	568,908 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$1.31 - $2.69 $500,847 - $1.03 Million	382,326 Added 204.91%	568,908 $1.06 Million
Q1 2022 Oct 27, 2022	SELL	$1.95 - $3.89 $745,535 - $1.49 Million	-382,326 Reduced 67.2%	186,582 $390,000
Q1 2022 May 13, 2022	BUY	$1.95 - $3.89 $152,322 - $303,863	78,114 Added 72.02%	186,582 $390,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $33,882 - $54,780	8,893 Added 8.93%	108,468 $427,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $336,563 - $532,726	99,575 New	99,575 $479,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account